Recommendations from the Clinical Toxicology Recommendations Collaborative on the administration of activated charcoal in acute oral overdose
Unknown authors
Published in Clinical Toxicology
Methodology
Systematic review and structured expert consensus process by an international workgroup convened by three clinical toxicology societies to produce recommendations on activated charcoal in acute oral overdose.
Key Findings
The workgroup found the evidence for improved clinical outcomes remains weak, and framed activated charcoal as appropriate in selected patients based on the toxicity of the agent ingested, time since ingestion and airway safety, rather than as a routine decontamination step.
Conclusions
Activated charcoal in overdose is a case-by-case clinical decision, not a default intervention; it has no role as a general-purpose "detox" supplement.
Limitations
Underlying evidence base is dominated by volunteer studies; recommendations rest substantially on expert consensus.
Supplements Studied
International consensus positions activated charcoal as a selective, case-by-case decision in acute overdose rather than routine decontamination.
Study Details
Access Study
Disclosures
Funding
Clinical Toxicology Recommendations Collaborative (professional societies).
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.